N-methyl-d-aspartic acid receptors are altered by stress and alcohol in Wistar-Kyoto rat brain.
Previous studies have shown that the Wistar-Kyoto (WKY) rat strain is more sensitive to stressors and consumes significant quantities of alcohol under basal as well as stressful conditions when compared to other strains. Given that the glutamate neurotransmitter system has been implicated in depression and addiction, the goals of the present study were to investigate the effects of stress and stress-alcohol interactions on N-methyl-d-aspartate (NMDA) receptors in the rat brain. Thus this study measured the binding of [(3)H] MK-801 to NMDA receptors in the prefrontal cortex (PFC), caudate putamen (CPu), nucleus accumbens (NAc), hippocampus (HIP) and basolateral amygdala (BLA) in WKY rats in comparison to the Wistar (WIS) rat strain. Our results suggested that while voluntary alcohol consumption did not alter NMDA receptors in the PFC, CPu or NAc in either rat strain, it increased NMDA receptors in the HIP and BLA in both strains. In contrast, chronic stress increased NMDA receptors in the PFC, CPu, NAc in WKY rats but not in WIS rats. Chronic stress also decreased NMDA receptors in the HIP and increased NMDA receptors in the BLA in both strains. Alcohol co-treatment with stress increased NMDA receptors in the PFC, CPu and NAc in WKY rats but not in WIS rats. Interestingly, while alcohol co-treatment did not reverse stress induced decreases in NMDA receptors in the HIP, it reduced the binding of NMDA receptors in the BLA to control levels in both strains. Thus it appears that NMDA receptors in the PFC, CPu and NAc may be more sensitive to the effects of stress and could be implicated in the stress-induced alcohol consumption behavior seen in WKY rats. In contrast, NMDA receptors in the HIP and BLA may reflect an adaptive response and may not be responsible for the stress susceptible phenotype of the WKY rat strain.
Lei
Y
Y
Department of Pharmaceutical Sciences, University of the Sciences in Philadelphia, 600 South, 43rd Street, Philadelphia, PA 19104, USA.
Tejani-Butt
S M
SM
D000222:Adaptation, Physiological; D000428:Alcohol Drinking; D000679:Amygdala / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D004198:Disease Susceptibility; D016291:Dizocilpine Maleate; D000431:Ethanol / Q000009:adverse effects*; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism; D008297:Male; D017072:Neostriatum / Q000187:drug effects / Q000378:metabolism; D009714:Nucleus Accumbens / Q000187:drug effects / Q000378:metabolism; D009928:Organ Specificity; D017397:Prefrontal Cortex / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D011921:Rats, Inbred WKY / Q000378:metabolism*; D017208:Rats, Wistar; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism*; D013045:Species Specificity; D013312:Stress, Physiological / Q000187:drug effects; D013315:Stress, Psychological / Q000378:metabolism*
D016194:Receptors, N-Methyl-D-Aspartate; D000431:Ethanol; D016291:Dizocilpine Maleate
Curr Neuropharmacol. 2005 Oct;3(4):281-97
18369402
Physiol Behav. 1993 Nov;54(5):845-52
8248372
J Neurophysiol. 2007 Dec;98(6):3185-96
17898152
Physiol Behav. 1994 Mar;55(3):433-9
8190758
Biol Psychiatry. 2002 May 15;51(10):775-87
12007451
J Comp Neurol. 1999 Jan 11;403(2):229-60
9886046
Mol Neurobiol. 2005 Dec;32(3):223-35
16385139
Am J Physiol. 1994 Feb;266(2 Pt 2):R353-60
8141389
Brain Res. 1994 Jun 27;649(1-2):27-35
7953642
J Neurochem. 1999 Aug;73(2):839-48
10428083
Am J Psychiatry. 1995 Mar;152(3):332-40
7864257
Ann N Y Acad Sci. 2003 Nov;1003:250-72
14684451
Am J Psychiatry. 2005 Aug;162(8):1515-20
16055774
Arch Gen Psychiatry. 1997 Apr;54(4):313-21
9107147
Nat Rev Neurosci. 2002 Jun;3(6):453-62
12042880
Drug Alcohol Depend. 2002 Jan 1;65(2):115-27
11772473
Brain Res. 2006 Feb 16;1073-1074:175-82
16457790
Alcohol Alcohol. 2005 Sep-Oct;40(5):349-58
16043436
Brain Res. 2005 Aug 9;1052(2):156-62
16009352
Synapse. 2001 Jun 1;40(3):180-3
11304755
Ann N Y Acad Sci. 2008 Oct;1139:10-9
18991843
Neurosci Biobehav Rev. 1981 Summer;5(2):247-51
7196554
J Abnorm Psychol. 1977 Apr;86(2):103-26
858828
Arch Gen Psychiatry. 1995 May;52(5):374-83
7726718
Trends Neurosci. 1998 Dec;21(12):505-9
9881846
Life Sci. 1987 Mar 30;40(13):1245-51
3561150
Physiol Behav. 1999 Aug;67(2):219-25
10477053
Brain Res Mol Brain Res. 1999 Oct 1;72(2):166-75
10529475
Drug Alcohol Depend. 2008 Jul 1;96(1-2):16-21
18358639
J Neurochem. 1993 Nov;61(5):1957-60
7901339
J Pharmacol Exp Ther. 2003 Dec;307(3):1020-9
14534353
Brain Res Mol Brain Res. 1995 Aug;32(1):94-108
7494468
Neuropsychopharmacology. 2000 Feb;22(2):191-9
10649831
Hippocampus. 2004;14(3):281-91
15132427
J Stud Alcohol. 1995 Sep;56(5):538-45
7475034
Alcohol. 2009 Nov;43(7):509-19
19913194
Neuropharmacology. 2001 May;40(6):749-60
11369029
Physiol Behav. 1994 May;55(5):975-8
8022922
Neuroscience. 1997 Mar;77(1):65-73
9044375
Acta Psychiatr Scand Suppl. 1999;395:20-9
10225329
Neuroreport. 2000 Feb 28;11(3):627-31
10718326
Neuron. 2000 Feb;25(2):449-57
10719898
Physiol Behav. 1996 Apr-May;59(4-5):983-9
8778896
J Neurochem. 2000 May;74(5):1798-808
10800922
Biol Psychiatry. 1996 May 1;39(9):808-13
8731522
Physiol Behav. 1989 Dec;46(6):993-8
2634265
Prog Neuropsychopharmacol Biol Psychiatry. 2003 Feb;27(1):7-14
12551720
Alcohol Clin Exp Res. 1994 Aug;18(4):1004-8
7978078
Alcohol Clin Exp Res. 1997 Nov;21(8):1508-19
9394125
Life Sci. 2009 Dec 16;85(23-26):794-9
19874829
J Neurochem. 1994 Apr;62(4):1635-8
8133290
J Neurosci. 2010 Apr 14;30(15):5357-67
20392957
Alcohol Alcohol. 1996 Jul;31(4):333-40
8879279
Drug Alcohol Rev. 2006 Nov;25(6):515-36
17132571
Trends Pharmacol Sci. 1992 May;13(5):206-11
1306042
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):70-5
18992785
Pharmacol Biochem Behav. 2010 Jan;94(3):471-6
19896970
J Consult Clin Psychol. 1997 Oct;65(5):715-26
9337490
J Neurochem. 1993 May;60(5):1650-7
8097232
Alcohol Clin Exp Res. 2003 Feb;27(2):232-43
12605072
Alcohol Clin Exp Res. 2005 Jun;29(6):1027-34
15976529
Physiol Behav. 1989 Sep;46(3):483-7
2623074
Eur J Pharmacol. 1990 Feb 13;176(3):289-96
2158451